vTv Therapeutics (VTVT) Misses Q1 EPS by 117c

vTv Therapeutics (NASDAQ: VTVT) reported Q1 EPS of ($1.17). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial